問卷

TPIDB > Search Result > Clinical Trials List

Clinical Trials List

Protocol NumberCSBR759A2202

2008-08-01 - 2010-03-31

Phase II

Terminated4

  • Trial Applicant

    NOVARTIS (TAIWAN) CO., LTD.

  • Sponsor

  • Trial scale

  • Update

    2025/08/20

Investigators and Locations

Principal Investigator 江守山

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator Hung-Chun CHEN

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator Jin-Bor Chen

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator 張家築

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Condition/Disease

Objectives

Test Drug

Active Ingredient

Dosage Form

Dosage

Endpoints

Inclution Criteria

The Estimated Number of Participants

  • Taiwan

    80 participants

  • Global

    200 participants